Plarit Tablet 90 mg contains Ticagrelor, a potent oral antiplatelet agent used to prevent thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (heart attack). Ticagrelor works by inhibiting platelet aggregation, reducing the risk of blood clot formation in arteries, and preventing complications such as heart attacks and strokes.

Unlike other antiplatelet medications, Ticagrelor is a reversible P2Y12 receptor antagonist, providing rapid and consistent platelet inhibition. Plarit Tablet 90 mg is often prescribed for patients at high risk of recurrent cardiovascular events, offering both short-term and long-term protection. It may be used alone or in combination with low-dose aspirin under medical supervision for dual antiplatelet therapy.

This formulation ensures fast absorption, predictable pharmacokinetics, and reliable platelet inhibition, making it suitable for both acute management and long-term prevention of cardiovascular complications.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Features

• Active Ingredient – Ticagrelor 90 mg: Potent antiplatelet therapy for cardiovascular protection.

• Prevents Heart Attack and Stroke: Reduces the risk of thrombotic events in high-risk patients.

• Rapid and Reversible Action: Provides quick and controlled platelet inhibition.

• Supports Acute Coronary Syndrome Management: Effective in unstable angina and myocardial infarction.

• Oral Tablet Formulation: Convenient once- or twice-daily dosing for consistent protection.

Indications

Plarit Tablet 90 mg is indicated for:

• Prevention of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS)

• Secondary prevention in patients with a history of myocardial infarction

• Reducing the risk of heart attack, stroke, and cardiovascular death in high-risk patients

• Part of dual antiplatelet therapy with low-dose aspirin, as recommended by a cardiologist

Mechanism of Action

Ticagrelor in Plarit Tablet works by:

1. P2Y12 Receptor Antagonism: Blocks ADP-mediated platelet activation, preventing aggregation.

2. Rapid Onset of Action: Quickly reduces platelet clumping to lower thrombus formation.

3. Reversible Inhibition: Allows controlled platelet function recovery when therapy is paused.

4. Enhanced Blood Flow: Helps maintain patency of coronary arteries and reduces ischemic events.

This mechanism ensures both immediate and sustained protection against clot formation in patients with cardiovascular risk.

Dosage and Administration

• Adults: 90 mg twice daily, orally, with or without food, or as prescribed by a physician.

• Typically used in combination with low-dose aspirin unless contraindicated.

• Swallow the tablet whole; do not crush or chew.

• Follow medical guidance carefully regarding duration and combination with other antiplatelet agents.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Safety and Precautions

• May increase the risk of bleeding; avoid use in patients with active bleeding, hemorrhagic stroke, or severe liver disease.

• Monitor for signs of prolonged bleeding, bruising, or black/tarry stools.

• Inform your doctor about all medications to prevent drug interactions, particularly anticoagulants or other antiplatelet drugs.

• Use caution in elderly patients or those with a history of gastrointestinal bleeding.

• Store in a cool, dry place below 25°C, away from light and moisture, and keep out of reach of children.

Plarit Tablet 90 mg offers effective and reliable antiplatelet therapy, reducing the risk of heart attack, stroke, and other thrombotic cardiovascular events, supporting both acute and long-term heart health.